Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Littleton, Colorado · 8199 SOUTHPARK LN STE 110, LITTLETON, CO 80120-5665 · (303) 795-5082
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in Littleton, Colorado. Active studies at this site cover conditions such as Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC) and Head and Neck Squamous Cell Carcinoma (HNSCC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (1)
More research sites in Littleton
- Rocky Mountain Cancer Centers-Littleton (11 trials)
- South Denver Cardiology Associates (6 trials)
- AdventHealth Littleton (4 trials)
- Rocky Mountain Cancer Centers, LLP (4 trials)
- Littleton Adventist Hospital (3 trials)
- Rocky Mountain Gastroenterology (3 trials)
- South Denver Cardiology (3 trials)
- South Denver Cardiology Associates, PC (3 trials)
- 89bio Clinical Study Site (2 trials)
- Rocky Mountain Cancer Centers (2 trials)
Explore more
Paid clinical trials in Littleton, CO · Colorado clinical trials